-
Mashup Score: 4What is the Risk for Peritoneal Metastases and Survival Afterwards in T4 Colon Cancers? - Annals of Surgical Oncology - 2 year(s) ago
Background Patients with T4 colon adenocarcinomas have an increased risk of peritoneal metastases (PM) but the histopathologic risk factors for its development are not well-described. Objective The purpose of this study was to determine factors associated with PM, time to recurrence, and survival after recurrence among patients with T4 colon cancer. Patients and Methods Patients with pathologic…
Source: SpringerLinkCategories: Hem/Onc News and Journals, Latest HeadlinesTweet
-
Mashup Score: 0What is the Risk for Peritoneal Metastases and Survival Afterwards in T4 Colon Cancers? - Annals of Surgical Oncology - 2 year(s) ago
Background Patients with T4 colon adenocarcinomas have an increased risk of peritoneal metastases (PM) but the histopathologic risk factors for its development are not well-described. Objective The purpose of this study was to determine factors associated with PM, time to recurrence, and survival after recurrence among patients with T4 colon cancer. Patients and Methods Patients with pathologic…
Source: SpringerLinkCategories: Hem/Onc News and Journals, Latest HeadlinesTweet-
JULY ISSUE: What is the Risk for #PeritonealMetastases and Survival Afterwards in #T4ColonCancers? https://t.co/qITbi0SrRu @McMastersKelly @SocSurgOnc https://t.co/90wt96OMzw
-
-
Mashup Score: 23
Background Diaphragmatic resection (DR) is often required during cytoreductive surgery/hyperthermic intraperitoneal chemotherapy (CRS/HIPEC) to achieve complete cytoreduction (CC). While CC provides the best survival, requiring a DR may indicate unfavorable tumor biology. We assessed how DR during CRS/HIPEC affects outcomes. Methods A retrospective cohort study was conducted using a prospective…
Source: SpringerLinkCategories: Hem/Onc News and Journals, Latest HeadlinesTweet-
Outcomes Following #CRS/HIPEC with and without #DiaphragmaticResection in Patients with #PeritonealMetastases . @ANikiforchin @VadimGushchin6 @mmsittig @KateBaronMD1 @FelipeLopezMD https://t.co/EiXAcLyBuE #VisualAbstract @McMastersKelly https://t.co/NhHqwnfJ8G
-
-
Mashup Score: 2
Gastric cancer (GC) is a common cancer worldwide, with patients developing isolated peritoneal metastases (PM) in approximately 30% of cases. In patients with PM, prognosis is quite poor, and long-term survival is almost zero. Cytoreductive surgery and hyperthermic intraperitoneal chemotherapy (CRS/HIPEC) has been demonstrated to be an effective treatment in many peritoneal malignancies,…
Source: Annals of Surgical OncologyCategories: Hem/Onc News and Journals, Latest HeadlinesTweet-
AUGUST ISSUE: The Landmark Series: #CytoreductiveSurgery and #HyperthermicIntraperitonealChemotherapy (CRS/HIPEC) for Treatment of #GastricCancer Metastatic to Peritoneum. #peritonealmetastases https://t.co/Jyr6OwYXRz @McMastersKelly @SocSurgOnc https://t.co/gxW2bTvZFC
-
-
Mashup Score: 11The Landmark Series: Surgical Treatment of Colorectal Cancer Peritoneal Metastases - Annals of Surgical Oncology - 3 year(s) ago
Background Peritoneal metastases (PM) are a form of metastatic spread affecting approximately 5-15% of colon cancer patients. The attitude towards management of peritoneal metastases has evolved from therapeutic nihilism towards a more comprehensive and multidisciplinary approach, in large part due to the development of cytoreductive surgery (CRS), usually coupled with heated intraperitoneal…
Source: Annals of Surgical OncologyCategories: Latest Headlines, Oncologists1Tweet-
RT @AnnSurgOncol: AUGUST ISSUE: The Landmark Series: Surgical Treatment of #ColorectalCancer #PeritonealMetastases. https://t.co/Vw1q2omRfX…
-
-
Mashup Score: 0The Landmark Series: Surgical Treatment of Colorectal Cancer Peritoneal Metastases - Annals of Surgical Oncology - 3 year(s) ago
Background Peritoneal metastases (PM) are a form of metastatic spread affecting approximately 5-15% of colon cancer patients. The attitude towards management of peritoneal metastases has evolved from therapeutic nihilism towards a more comprehensive and multidisciplinary approach, in large part due to the development of cytoreductive surgery (CRS), usually coupled with heated intraperitoneal…
Source: Annals of Surgical OncologyCategories: Hem/Onc News and Journals, Latest HeadlinesTweet-
AUGUST ISSUE: The Landmark Series: Surgical Treatment of #ColorectalCancer #PeritonealMetastases. https://t.co/Vw1q2omRfX @McMastersKelly @SocSurgOnc https://t.co/jZGWndwIYp
-
-
Mashup Score: 0
Gastric cancer (GC) is a common cancer worldwide, with patients developing isolated peritoneal metastases (PM) in approximately 30% of cases. In patients with PM, prognosis is quite poor, and long-term survival is almost zero. Cytoreductive surgery and hyperthermic intraperitoneal chemotherapy (CRS/HIPEC) has been demonstrated to be an effective treatment in many peritoneal malignancies,…
Source: Annals of Surgical OncologyCategories: Hem/Onc News and Journals, Latest HeadlinesTweet-
AHEAD OF PRINT: The Landmark Series: #CytoreductiveSurgery and #HyperthermicIntraperitonealChemotherapy (CRS/HIPEC) for Treatment of #GastricCancer Metastatic to Peritoneum. #peritonealmetastases https://t.co/TqRR7n2wsr @McMastersKelly @SocSurgOnc https://t.co/3Wag8B357i
-
-
Mashup Score: 0The Chicago Consensus on Peritoneal Surface Malignancies: Management of Gastric Metastases - 4 year(s) ago
The Chicago Consensus Working Group provides multidisciplinary recommendations for the management of gastric cancer specifically as it relates to the management of peritoneal surface malignancy. These guidelines are developed with input from leading experts including surgical oncologists, medical oncologists, pathologists, radiologists, palliative care physicians, and pharmacists. These…
Source: Annals of Surgical OncologyCategories: Hem/Onc News and Journals, Latest HeadlinesTweet-
ONLINE FIRST: Treatment strategies for mgmt of #GastricCancer with #PeritonealMetastases based on best available evidence. #ChicagoConsensusWorkingGroup. #consensus @kturaga . @McMastersKelly @SocSurgOnc https://t.co/ClEfvY92q7 https://t.co/dvQ3fUM5oh
-
-
Mashup Score: 1
The aim of this study was to determine whether the extent of peritoneal metastases (PMs) on preoperative diffusion-weighted magnetic resonance imaging (DW-MRI) can be used as a biomarker of disease-free and overall survival in patients with colorectal cancer who are considered for cytoreductive surgery and hyperthermic intraperitoneal chemotherapy (CRS/HIPEC). For this retrospective cohort study,…
Source: Annals of Surgical OncologyCategories: Hem/Onc News and JournalsTweet-
AHEAD OF PRINT: Extent of #PeritonealMetastases on Preoperative DW-MRI is Predictive of Disease-Free and Overall Survival for CRS/HIPEC Candidates with #ColorectalCancer. https://t.co/93ULxJ8oAn @McMastersKelly @SocSurgOnc https://t.co/KQV5ATw6c0
-
From @AnnSurgOncol: What is the Risk for #PeritonealMetastases and Survival Afterwards in T4 #ColonCancers? https://t.co/VbhDnhBzRW @McMastersKelly https://t.co/IxtvsmeRup